带状疱疹可能是潜伏性 COVID-19 感染的一个指标。
Herpes zoster might be an indicator for latent COVID 19 infection.
机构信息
Department of Dermatology and Venereology, National Research Centre, Giza, Egypt.
Department of Clinical Pathology, Cairo University, Giza, Egypt.
出版信息
Dermatol Ther. 2020 Jul;33(4):e13666. doi: 10.1111/dth.13666. Epub 2020 Jun 11.
Abstract
Various cutaneous manifestations have been observed in patients with COVID-19 infection. Herpes zoster is a viral skin disease caused by varicella zoster that remains dormant in the dorsal root ganglia of cutaneous nerves following a primary chicken pox infection. In this report, we describe two cases COVID infection who first presented with herpes zoster. We are here by suggesting that the clinical presentation of HZ at the time of the current pandemic even in patients giving mild or no suggestive history of upper respiratory symptoms should be considered as an alarming sign for a recent subclinical SARS CoV2 infection.
摘要
在 COVID-19 感染患者中观察到各种皮肤表现。带状疱疹是一种由水痘带状疱疹病毒引起的病毒性皮肤病，在原发水痘感染后潜伏在皮肤神经的背根神经节中。在本报告中，我们描述了两例 COVID 感染患者，他们最初表现为带状疱疹。我们建议，即使在轻症或无明显上呼吸道症状史的患者中，当前大流行期间带状疱疹的临床表现也应被视为近期亚临床 SARS CoV2 感染的警报信号。
相似文献
1
Herpes zoster might be an indicator for latent COVID 19 infection.带状疱疹可能是潜伏性 COVID-19 感染的一个指标。
Dermatol Ther. 2020 Jul;33(4):e13666. doi: 10.1111/dth.13666. Epub 2020 Jun 11.
2
Herpes zoster in COVID-19-positive patients.新冠病毒检测呈阳性患者中的带状疱疹
Int J Dermatol. 2020 Aug;59(8):1028-1029. doi: 10.1111/ijd.15001. Epub 2020 Jun 12.
3
Herpes zoster (shingles) complicating the course of COVID19 infection.带状疱疹（俗称“蛇缠腰”）使 COVID19 感染的病程复杂化。
J Dermatolog Treat. 2022 Mar;33(2):1123-1125. doi: 10.1080/09546634.2020.1782823. Epub 2020 Oct 12.
4
Herpes zoster may be a marker for COVID-19 infection during pregnancy.带状疱疹可能是妊娠期 COVID-19 感染的标志物。
Cutis. 2020 Dec;106(6):318-320. doi: 10.12788/cutis.0133.
5
Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report.幼儿水痘带状疱疹病毒感染后 4 天因 SARS-CoV-2 再激活而出现带状疱疹进展;病例报告。
BMC Infect Dis. 2023 Dec 6;23(1):854. doi: 10.1186/s12879-023-08809-5.
6
Experience with Hemodialysis Patients in the COVID-19 Pandemic in Sakarya, Turkey.土耳其萨卡里亚在新冠疫情期间对血液透析患者的经验。
J Coll Physicians Surg Pak. 2020 Oct;30(10):138. doi: 10.29271/jcpsp.2020.supp2.138.
7
SARS-CoV-2 and EBV coinfection.严重急性呼吸综合征冠状病毒2型与EB病毒合并感染。
Med Clin (Barc). 2020 Oct 9;155(7):319-320. doi: 10.1016/j.medcli.2020.06.017. Epub 2020 Jun 25.
8
Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.COVID-19 的皮肤表现：三例病例报告及文献复习。
J Dermatol Sci. 2020 May;98(2):75-81. doi: 10.1016/j.jdermsci.2020.04.011. Epub 2020 Apr 29.
9
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.中国肺炎患者同时感染 SARS-CoV-2 和甲型流感病毒。
Emerg Infect Dis. 2020 Jun;26(6):1324-1326. doi: 10.3201/eid2606.200299. Epub 2020 Jun 17.
10
Herpes zoster ophthalmicus in COVID-19 patients.新冠病毒感染患者中的眼部带状疱疹
Int J Dermatol. 2020 Dec;59(12):1545-1546. doi: 10.1111/ijd.15240. Epub 2020 Oct 11.
引用本文的文献
1
Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: A systematic review.新型冠状病毒肺炎合并疱疹病毒共同感染或再激活患者的临床特征及预后：一项系统评价
New Microbes New Infect. 2024 Feb 18;58:101233. doi: 10.1016/j.nmni.2024.101233. eCollection 2024 Apr.
2
Association between COVID-19 infection and herpes zoster: A case series.2019冠状病毒病感染与带状疱疹之间的关联：病例系列
J Family Med Prim Care. 2023 Oct;12(10):2516-2519. doi: 10.4103/jfmpc.jfmpc_2112_22. Epub 2023 Oct 11.
3
Ramsay Hunt Syndrome in Asymptomatic COVID-19 Infection: A Case Report and a Literature Review.无症状 COVID-19 感染中的拉姆齐·亨特综合征：一例报告及文献综述
J Clin Med. 2023 Nov 29;12(23):7407. doi: 10.3390/jcm12237407.
4
Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.与女性感染 COVID-19 后相关的毛发疾病：一项横断面研究。
Ir J Med Sci. 2024 Apr;193(2):761-767. doi: 10.1007/s11845-023-03509-0. Epub 2023 Sep 14.
5
Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study.在埃及人群中，借助皮肤镜检查 COVID-19 疫苗接种后脱发的患病率：一项横断面研究。
Ir J Med Sci. 2024 Apr;193(2):755-760. doi: 10.1007/s11845-023-03493-5. Epub 2023 Aug 15.
6
Coronavirus disease 19 (COVID-19) and viral keratouveitis - unraveling the mystery.新型冠状病毒肺炎（COVID-19）与病毒性角结膜炎——揭开谜团。
Indian J Ophthalmol. 2023 Aug;71(8):3103-3108. doi: 10.4103/IJO.IJO_593_23.
7
Clinico-Demographic Profiles of Herpes Zoster Cases in Patients With and Without COVID-19 Infection During the Pandemic: A Retrospective Analysis of 32 Cases.疫情期间感染和未感染新冠病毒患者的带状疱疹病例临床人口统计学特征：32例回顾性分析
Cureus. 2023 Jun 6;15(6):e40063. doi: 10.7759/cureus.40063. eCollection 2023 Jun.
8
Cutaneous Manifestation in COVID-19: A Lesson Over 2 Years Into the Pandemic.COVID-19 相关皮肤表现：大流行 2 年多来的教训。
Clin Med Res. 2023 Mar;21(1):36-45. doi: 10.3121/cmr.2023.1598.
9
Herpes zoster in children during the COVID-19 pandemic in France: A retrospective multicenter observational study.法国新冠肺炎疫情期间儿童带状疱疹：一项回顾性多中心观察性研究。
Ann Dermatol Venereol. 2023 Mar;150(1):46-48. doi: 10.1016/j.annder.2022.08.003. Epub 2023 Feb 20.
10
Clinical characteristics and outcomes of patients with Herpes Zoster Infection in the context of SARS-CoV-2 infection. A case report and a systematic review.新型冠状病毒感染背景下带状疱疹感染患者的临床特征与结局。一例病例报告及系统评价。
Qatar Med J. 2022 Sep 1;2022(3):41. doi: 10.5339/qmj.2022.41. eCollection 2022.
本文引用的文献
1
Cutaneous signs in COVID-19 patients: A review.COVID-19 患者的皮肤表现：综述。
Dermatol Ther. 2020 Sep;33(5):e13549. doi: 10.1111/dth.13549. Epub 2020 May 29.
2
SARS-CoV-2 and viral sepsis: observations and hypotheses.SARS-CoV-2 与病毒败血症：观察与假说。
Lancet. 2020 May 9;395(10235):1517-1520. doi: 10.1016/S0140-6736(20)30920-X. Epub 2020 Apr 17.
3
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病（COVID-19）严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常：荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.
4
COVID-19: immunopathology and its implications for therapy.新型冠状病毒肺炎：免疫病理学及其治疗意义。
Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.
5
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.中国湖北省外指定传染病医院的 COVID-19 疫情。
Allergy. 2020 Jul;75(7):1742-1752. doi: 10.1111/all.14309. Epub 2020 Apr 17.
6
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.从基因组角度看 SARS-CoV-2 的起源与出现。
Cell. 2020 Apr 16;181(2):223-227. doi: 10.1016/j.cell.2020.03.035. Epub 2020 Mar 26.
7
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?新冠病毒感染中针对过度炎症反应的免疫抑制：一把双刃剑？
Lancet. 2020 Apr 4;395(10230):1111. doi: 10.1016/S0140-6736(20)30691-7. Epub 2020 Mar 24.
8
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
9
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.外周血中T细胞的疲惫水平升高和功能多样性降低可能预示着新冠病毒疾病（COVID-19）患者病情的严重进展。
Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.
10
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
Zotero 插件